1. Home
  2. ELOG vs ENSC Comparison

ELOG vs ENSC Comparison

Compare ELOG & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

SELL

Current Price

$1.00

Market Cap

6.4M

Sector

Industrials

ML Signal

SELL

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

SELL

Current Price

$0.56

Market Cap

7.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ELOG
ENSC
Founded
2006
2003
Country
China
United States
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
7.6M
IPO Year
2024
2017

Fundamental Metrics

Financial Performance
Metric
ELOG
ENSC
Price
$1.00
$0.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
87.4K
★ 464.1K
Earning Date
11-19-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.24
EPS
★ N/A
N/A
Revenue
N/A
★ $5,066,650.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.84
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.40
$0.23
52 Week High
$2.93
$2.75

Technical Indicators

Market Signals
Indicator
ELOG
ENSC
Relative Strength Index (RSI) 81.58 73.13
Support Level $0.82 $0.47
Resistance Level $1.15 $0.61
Average True Range (ATR) 0.09 0.04
MACD 0.06 0.01
Stochastic Oscillator 79.48 91.64

Price Performance

Historical Comparison
ELOG
ENSC

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: